Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Trials|April 11, 2020
Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated eventsAlexander C Fanaroff, Ghazala Haque, Betsy Thomas, et al.
The American Journal of Cardiology|July 7, 2009
Predictors of early discontinuation of evidence-based medicine after acute coronary syndromeChiara Melloni, Karen P Alexander, Fang-Shu Ou, et al.
American Heart Journal|August 8, 2025
Medicare Coverage Gap Status, Adherence to Oral Anticoagulation, and Stroke Rates in Patients with Atrial FibrillationJosephine Harrington, Rohin K Reddy, Anthony Carnicelli, et al.
American Heart Journal|May 4, 2010
Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiativeShahyar Michael Gharacholou, Karen P Alexander, Anita Y Chen, et al.
American Heart Journal|July 29, 2008
Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromesChiara Melloni, Karen P Alexander, Anita Y Chen, et al.
Therapeutic Drug Monitoring|June 4, 2016
Therapeutic Drug Monitoring, Electronic Health Records, and Pharmacokinetic Modeling to Evaluate Sirolimus Drug Exposure-Response Relationships in Renal Transplant PatientsKanecia O Zimmerman, Huali Wu, Rachel Greenberg, et al.
Therapeutic Drug Monitoring|October 21, 2016
Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and LamotrigineLawrence C Ku, Huali Wu, Rachel G Greenberg, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report FormsMary Elizabeth Sabol, John Finkle, Mitch Krucoff, et al.
European Heart Journal. Acute Cardiovascular Care|August 1, 2015
Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS TrialChiara Melloni, Jan H Cornel, Gail Hafley, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2014
Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study designAdriana Tremoulet, Jennifer Le, Brenda Poindexter, et al.
Pageof 8